Table 5.

Cumulative incidence probability for death and renal replacement therapy between the groups (cancer vs no cancer) in the matched sample in a competing risk analysis

Years from study entry	Groups	Death	Renal replacement therapy
5	Cancer	0.36	0.16
	No cancer	0.23	0.20
10	Cancer	0.57	0.19
	No cancer	0.47	0.21
15	Cancer	0.70	0.20
	No cancer	0.63	0.25
	p -Value	0.001	0.39

p-Value by modified X² test by Gray. Statistically significant p-values are displayed in bold (i.e. p < 0.05)